New Stock News | Rongtai Pharmaceutical Files Second Application with Hong Kong Stock Exchange

According to the disclosure of the Hong Kong Stock Exchange on May 22, Guangdong Rongtai Pharmaceutical Co., Ltd. (referred to as Rongtai Pharmaceutical) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with CITIC SEC as the sole sponsor. The company had previously submitted its listing application to the Hong Kong Stock Exchange on September 26, 2025. According to the prospectus, Rongtai Pharmaceutical is a leading provider of digital marketing and supply chain services for China's major out-of-hospital pharmaceutical market. The company is engaged in online and offline pharmaceutical retail and wholesale businesses, with revenue mainly coming from (i) individual customers through third-party e-commerce platforms and the company's online store; (ii) grassroots end customers through regional sales partners and online stores; and (iii) pharmaceutical sales to chain pharmacies.